gip glp 1 agonist Possible mechanisms of the interaction of and GLP-1 for treatment Mechanisms of action and therapeutic
Description
202201011395 to X.L
The data for this one is just not quite there
A ResMed-supported study found that, after one year, there was no significant difference in CPAP adherence or discontinuation rates among recent GLP-1 users with OSA
107,203 The physiological relevance of GLP-1 metabolites remains an area of controversy
This requires provider management of the dose escalation on the new medication
